Literature DB >> 1554372

Comparison of liver glycosylasparaginases from six vertebrates.

O K Tollersrud1, N N Aronson.   

Abstract

Structural and physical properties of glycosylasparaginase (EC 3.5.1.26) from the livers of human, pig, cow, rat, mouse and chicken were compared. The enzyme in all species had a common basic structure of two N-glycosylated subunits of about 24 (alpha) and 20 (beta) kDa joined by non-covalent forces. Subunit-specific antisera against the rat glycosylasparaginase bound specifically and sensitively to the corresponding subunits from all species. Identity of 80% of the amino acids was found between the N-terminal sequences of corresponding pig and rat glycosylasparaginase alpha- and beta-subunits and the deduced sequence from a human glycosylasparaginase cDNA [Fisher, Tollersrud & Aronson (1990) FEBS Lett. 269, 440-444]. The beta-subunit from all three species has an N-terminal threonine reported to be involved in the reaction mechanism for the human enzyme [Kaartinen, Williams, Tomich, Yates, Hood & Mononen (1991) J. Biol. Chem. 266, 5860-5869]. The native enzyme appeared as a heterodimer among the mammals, whereas the chicken enzyme had a greater molecular mass and is probably either a tetramer or a heterodimer bound to an unrelated peptide(s). All glycosylasparaginases were thermostable, requiring temperatures between 65 degrees C and 80 degrees C to be irreversibly inactivated. In addition, they were unusually stable at high pH and remained active in the presence of SDS except at low pH. The pH maximum was between 5.5 and 6 except for the rat and mouse enzymes which had a broad maximum between pH 7 and 8. A number of other properties were observed which also distinguish the enzyme from individual and closely related species.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554372      PMCID: PMC1130871          DOI: 10.1042/bj2820891

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Purification and properties of 4-L-aspartylglycosylamine amidohydrolase from hog kidney.

Authors:  M Kono; I Yamashina
Journal:  Biochim Biophys Acta       Date:  1972-02-28

2.  Studies on enzymes acting on glycopeptides.

Authors:  M Makino; T Kojima; T Ohgushi; I Yamashina
Journal:  J Biochem       Date:  1968-02       Impact factor: 3.387

3.  Isolation of a human hepatic 60 kDa aspartylglucosaminidase consisting of three non-identical polypeptides.

Authors:  M Baumann; L Peltonen; P Aula; N Kalkkinen
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

4.  Disulphide bridges in globular proteins.

Authors:  J M Thornton
Journal:  J Mol Biol       Date:  1981-09-15       Impact factor: 5.469

5.  Aspartylglycosaminuria in the Finnish population: identification of two point mutations in the heavy chain of glycoasparaginase.

Authors:  I Mononen; N Heisterkamp; V Kaartinen; J C Williams; J R Yates; P R Griffin; L E Hood; J Groffen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 6.  Lysosomal degradation of Asn-linked glycoproteins.

Authors:  N N Aronson; M J Kuranda
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.191

7.  The isolation and structure of the core oligosaccharide sequences of IgM.

Authors:  A L Tarentino; T H Plummer; F Maley
Journal:  Biochemistry       Date:  1975-12-16       Impact factor: 3.162

8.  Lysosomal alpha-D-mannosidase of rat liver. Purification and comparison with the golgi and cytosolic alpha-D-mannosidases.

Authors:  D J Opheim; O Touster
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

Review 9.  Aspartylglycosaminuria: an inborn error of glycoprotein catabolism.

Authors:  C P Maury
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

10.  Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease.

Authors:  E Ikonen; M Baumann; K Grön; A C Syvänen; N Enomaa; R Halila; P Aula; L Peltonen
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  8 in total

1.  Crystal structure of glycosylasparaginase from Flavobacterium meningosepticum.

Authors:  J Xuan; A L Tarentino; B G Grimwood; T H Plummer; T Cui; C Guan; P Van Roey
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

2.  The T99K variant of glycosylasparaginase shows a new structural mechanism of the genetic disease aspartylglucosaminuria.

Authors:  Suchita Pande; Hwai-Chen Guo
Journal:  Protein Sci       Date:  2019-04-09       Impact factor: 6.725

3.  Single base deletion in exon 7 of the glycosylasparaginase gene causes a mild form of aspartylglycosaminuria in a patient of Mauritian origin.

Authors:  H Park; M Rossiter; A H Fensom; B Winchester; N N Aronson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Biochemical and structural insights into an allelic variant causing the lysosomal storage disorder - aspartylglucosaminuria.

Authors:  Suchita Pande; William Bizilj; Hwai-Chen Guo
Journal:  FEBS Lett       Date:  2018-07-23       Impact factor: 4.124

5.  Human leucocyte glycosylasparaginase is an alpha/beta-heterodimer of 19 kDa alpha-subunit and 17 and 18 kDa beta-subunit.

Authors:  O K Tollersrud; T Heiskanen; L Peltonen
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

6.  Biochemical characterization and comparison of aspartylglucosaminidases secreted in venom of the parasitoid wasps Asobara tabida and Leptopilina heterotoma.

Authors:  Quentin Coulette; Séverine Lemauf; Dominique Colinet; Geneviève Prévost; Caroline Anselme; Marylène Poirié; Jean-Luc Gatti
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

Review 7.  Structural and biophysical aspects of l-asparaginases: a growing family with amazing diversity.

Authors:  Joanna I Loch; Mariusz Jaskolski
Journal:  IUCrJ       Date:  2021-06-30       Impact factor: 4.769

8.  Lysosomal aspartylglucosaminidase is processed to the active subunit complex in the endoplasmic reticulum.

Authors:  E Ikonen; I Julkunen; O K Tollersrud; N Kalkkinen; L Peltonen
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.